The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape, Cancer Immunol Immunother, vol.53, p.904, 2004. ,
Infusion of Melan-A/Mart-1 speciWc tumor-inWltrating lymphocytes enhanced relapse-free survival of melanoma patients, Cancer Immunol Immunother, vol.56, issue.4, pp.515-526, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-02482050
Human T Cell responses against melanoma, Annu Rev Immunol, vol.24, p.175, 2006. ,
The case for therapeutic vaccines, Melanoma Res, vol.6, p.5, 1996. ,
Randomized trial of adoptive transfert of melanoma Tumor InWltrating Lymphocytes (TIL) as adjuvant therapy in melanoma stage III, Cancer Immunol Immunother, vol.10, p.539, 2002. ,
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma, J Clin Oncol, vol.23, p.2346, 2005. ,
A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-speciWc T lymphocytes in patients with metastatic melanoma, J Immunother, vol.25, issue.3, p.243, 2002. ,
Intérêt et limites des analyses en sous-groupes dans les essais thérapeutiques "Mode d'emploi des analyses en sous-groupes, vol.7, p.75, 2005. ,
MHC antigens and tumor escape from immune surveillance, Adv Cancer Res, vol.83, p.117, 2001. ,
High-fold expansion of human cytotoxic T-lymphocytes speciWc for autologous melanoma cells for use in immunotherapy, J Immunother, vol.10, p.405, 1991. ,
Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-inWltrating T lymphocytes associated with in vivo tumor regression, J Immunol, vol.154, p.3961, 1995. ,
CD4(+)CD25 high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers, Cancer Immunol Immunother, vol.55, p.1064, 2006. ,
Therapeutic eYcacy of melanoma reactive TIL infused to melanoma stage III patients, Cancer Immunol Immunother, vol.10, p.532, 2002. ,
High-scale expansion of melanoma-reactive TIL by a polyclonal stimulus: predictability and relation with disease advancement, Cancer Immunol Immunother, vol.50, issue.3, p.134, 2001. ,
Tissue prognostic markers for adoptive immunotherapy in melanoma, Eur J Dermatol, vol.17, issue.4, 2007. ,
Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy, J Immunol, vol.173, p.7125, 2004. ,
A new approach to the adoptive immunotherapy of cancer with tumor-inWltrating lymphocytes, Science, vol.233, p.1318, 1986. ,
Impaired surface antigen presentation in tumors: implications for T cell-based immunotherapy, Semin Cancer Biol, vol.12, p.15, 2002. ,